Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa (scientific article published on 7 July 2016)

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

Q28534323

An automated genotyping system for analysis of HIV-1 and other microbial sequences

Q33220974

Strategies for promoting adherence to antiretroviral therapy: a review of the literature

Q33764003

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa

Q34040005

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.

Q34102202

High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa

Q34629087

Treatment outcomes after 7 years of public-sector HIV treatment

Q36693557

Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.

Q36749434

Managed problem solving for antiretroviral therapy adherence: a randomized trial

Q37317759

Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment

Q37386000

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

Q37578947

Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis

Q37982191

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda

Q38869763

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial

Q39276881

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia

Q43594543

P433

issue

P921

main subject

South Africa

Q258

Johannesburg

Q34647

anti-retroviral agent

Q50430310

P304

page(s)

1131-1137

P577

publication date

2016-07-07

P1433

published in

Tropical Medicine and International Health

Q15765747

P1476

title

Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa

P478

volume

Reverse relations

cites work (P2860)

Q47258937	Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysi
Q61799469	Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues
Q50052129	HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
Q92590096	High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania - A prospective cohort study
Q53694767	Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.
Q53694036	Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
Q92751493	Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study
Q92251852	Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis
Q49797801	Social and behavioral factors associated with failing second-line ART - results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa
Q92350473	Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
Q58576647	Third-line antiretroviral therapy programme in the South African public sector: cohort description and virological outcomes
Q99551930	Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment

P356	DOI	10.1111/TMI.12741
P8608	Fatcat ID	release_6phf6ai6yba6zhp4vjf3xejwtm
P698	PubMed publication ID	27383454